Screener
DENTSPLY SIRONA XRAY SG&A
SG&A at other companies
Other financials
Where this comes from
Reported directly by DENTSPLY SIRONA in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: DENTSPLY SIRONA’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:56 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000818479-26-000255
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net sales | $898 | $936 | $1,778 | $1,815 |
| Cost of products sold | 405 | 446 | 858 | 859 |
| Gross profit | 493 | 490 | 920 | 956 |
| Selling, general, and administrative expenses | 364 | 342 | 715 | 700 |
| Research and development expenses | 45 | 37 | 89 | 73 |
| Goodwill and intangible asset impairments | — | 235 | — | 235 |
| Restructuring and other costs | 2 | 4 | 69 | 13 |
| Operating income (loss) | 82 | (128) | 47 | (65) |
Item 1 – Financial Statements
FAQ
- What is DENTSPLY SIRONA's SG&A?
- DENTSPLY SIRONA (XRAY) reported SG&A of $364M in Q2 2026.
- How has DENTSPLY SIRONA's SG&A changed year-over-year?
- DENTSPLY SIRONA's SG&A increased by 6.4% year-over-year, from $342M to $364M.
- What is the long-term trend for DENTSPLY SIRONA's SG&A?
- Over 4 years (2021 to 2025), DENTSPLY SIRONA's SG&A has grown at a -1.9% compound annual growth rate (CAGR), from $1.55B to $1.44B.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about DENTSPLY SIRONA's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude